New Blood Test to Significantly Improve Detection of Recurring Cancer
A new blood test known as Signatera has shown incredible ability to detect cancer relapses long before traditional scans, making it a game changer for patients.
Month: July 2021
New Parp Inhibitor Lynparza May Be Important Tool for Treating Early-Stage Breast Cancer
The President of the American Society for Clinical Oncology shared that new research has found that the Lynparza parp inhibitor could have a significant impact on the treatment and decision paths of patients with both high-risk and early-stage breast cancer. The study also showed that Lynparza reduces the chances that patients with the BRCA gene … Read more